Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SLE: reconciling heterogeneity
Michael D. Lockshin, Medha Barbhaiya, Peter Izmirly, et al.
Lupus Science & Medicine (2019) Vol. 6, Iss. 1, pp. e000280-e000280
Open Access | Times Cited: 19

Showing 19 citing articles:

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial
David Isenberg, Richard Furie, Nicholas S. Jones, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 10, pp. 1835-1846
Open Access | Times Cited: 95
An introduction to machine learning and analysis of its use in rheumatic diseases
Kathryn M. Kingsmore, Christopher Puglisi, Amrie C. Grammer, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 12, pp. 710-730
Closed Access | Times Cited: 52
Developing real‐world evidence from real‐world data: Transforming raw data into analytical datasets
Lisa Bastarache, Jeffrey S. Brown, James J. Cimino, et al.
Learning Health Systems (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 43
Autoantibodies in SLE: prediction and thepvalue matrix
May Y. Choi, Marvin J. Fritzler
Lupus (2019) Vol. 28, Iss. 11, pp. 1285-1293
Closed Access | Times Cited: 32
Quaternary Ammonium Compound Disinfectants Reduce Lupus-Associated Splenomegaly by Targeting Neutrophil Migration and T-Cell Fate
Leila Abdelhamid, Xavier Cabana-Puig, Qinghui Mu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 20
Implications of Endogenous Retroelements in the Etiopathogenesis of Systemic Lupus Erythematosus
Kennedy C. Ukadike, Tomas Mustelin
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 856-856
Open Access | Times Cited: 17
Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic
Е. Л. Насонов, Т. В. Попкова, T. A. Panafidina
Rheumatology Science and Practice (2021) Vol. 59, Iss. 2, pp. 119-128
Open Access | Times Cited: 17
Partial Protection From Lupus-Like Disease by B-Cell Specific Type I Interferon Receptor Deficiency
Emma J. Keller, Neeva B. Patel, Madeline Patt, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 13
Altered B cell phenotype and CD27+ memory B cells are associated with clinical features and environmental exposure in Colombian systemic lupus erythematosus patients
Carolina Hurtado, Diego Fernando Rojas‐Gualdrón, Rodrigo Urrego, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
Richard Dimelow, Beulah Ji, Herbert Struemper
Clinical Pharmacology in Drug Development (2020) Vol. 10, Iss. 6, pp. 622-633
Open Access | Times Cited: 14
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus
Katherine Nay Yaung, Joo Guan Yeo, Pavanish Kumar, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 3, pp. e151-e165
Open Access | Times Cited: 4
SLE classification criteria: Is “The causality principle” integrated and operative – and do the molecular and genetical network, on which criteria depend on, support the definition of SLE as “a one disease entity” – A theoretical discussion
Ole Petter Rekvig
Autoimmunity Reviews (2023) Vol. 22, Iss. 12, pp. 103470-103470
Open Access | Times Cited: 4
Nlrp12 deficiency alters gut microbiota and ameliorates Faslpr-mediated systemic autoimmunity in male mice
Leila Abdelhamid, Jiangdi Mao, Xavier Cabana-Puig, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Assisted reproductive technologies for women with rheumatic AID
Michael D. Lockshin
Best Practice & Research Clinical Obstetrics & Gynaecology (2019) Vol. 64, pp. 85-96
Closed Access | Times Cited: 8
Evaluation of the EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population‐Based Registry
Allison Guttmann, Brendan Denvir, Martin Aringer, et al.
Arthritis Care & Research (2022) Vol. 75, Iss. 5, pp. 1007-1016
Open Access | Times Cited: 4
Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development
Claudio Cruciani, Mariele Gatto, Luca Iaccarino, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 8, pp. 801-814
Closed Access
Differences between acute and chronic disease: comment on the article by Holman
Michael D. Lockshin
ACR Open Rheumatology (2020) Vol. 2, Iss. 5, pp. 300-300
Open Access | Times Cited: 2
Recent advances in the treatment of systemic lupus erythematosus with belimumab in children.
Weiping Deng
PubMed (2021)
Closed Access | Times Cited: 2
Hypovitaminosis A Drives the Progression of Tubulointerstitial Lupus Nephritis through Potentiating Predisease Cellular Autoreactivity
Leila Abdelhamid, Razan Alajoleen, Kathryn M. Kingsmore, et al.
ImmunoHorizons (2023) Vol. 7, Iss. 1, pp. 17-29
Open Access
Page 1

Scroll to top